Aller is a high profile clinical researcher who has seen Naturalvue in action for many years (was an author on past key papers about Naturalvue), and now has an addition 4 year study that should appear soon.
Nice commentary on the results both from the RCT and his forthcoming work. Looks like further verification of the efficacy of our product.
Ann: VTI Announces Positive Interim 1-Year PROTECT Results, page-5
Add VTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.806M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 16.0¢ | $7.384K | 46.15K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6250 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 15511 | 2 |
View Market Depth
| Last trade - 14.53pm 05/06/2024 (20 minute delay) ? |
| VTI (ASX) Chart |